Cambendazole in the treatment of human strongyloidiasis.

Abstract

Cambendazole was used for the treatment of strongyloidiasis in 40 hospitalized patients, given in a single dose of 5 mg/kg body weight. According to the criteria adopted, parasitological cure was obtained in 100% of cases. Side effects were negligible, and did not require interruption of treatment. We therefore conclude that cambendazole is at present the most effective agent for the therapy of human strongyloidiasis.

• Authors: S A Bicalho, O J Leão, Q Pena Jr
• Journal: The American journal of tropical medicine and hygiene (Am J Trop Med Hyg) Vol. 32 Issue 5 Pg. 1181-3 (Sep 1983) ISSN: 0002-9637 [Print] United States
• PMID: 6625071 (Publication Type: Journal Article)

Chemical References

• Benzimidazoles
• Cambendazole

Topics

• Adolescent
• Adult
• Aged
• Benzimidazoles (therapeutic use)
• Cambendazole (adverse effects, therapeutic use)
• Drug Evaluation
• Female
• Humans
• Male
• Middle Aged
• Strongyloidiasis (drug therapy)